Free practice question: Apixaban before a stimulator trial
Question 20 of 25 in the free Starter set. Single best answer, three options, like the real exam.
G4a · General considerations
A 67-year-old man with persistent spinal pain after lumbar fusion is scheduled for a percutaneous spinal cord stimulator trial. He takes apixaban 5 mg twice daily for nonvalvular atrial fibrillation (CHA2DS2-VASc score 2, no prior stroke), and his creatinine clearance is 75 mL/min. His cardiologist agrees to a brief interruption. What is the most appropriate periprocedural plan for apixaban?
Review the topic: Anticoagulants and antiplatelets for interventional pain procedures · Spinal cord stimulation: selection, trials, evidence, complications
Full access: the whole question bank and timed mock exams
One payment, no subscription. Bought separately from APPLIED. Full refund within 7 days.
Already have access? Sign in